Inhibition of cyclooxygenase-2 improves cardiac function in myocardial infarction

被引:61
|
作者
Saito, T
Rodger, IW
Hu, F
Shennib, H
Giaid, A
机构
[1] Montreal Gen Hosp, Dept Pathol, Montreal, PQ H3G 1A4, Canada
[2] Montreal Gen Hosp, Dept Med, Montreal, PQ H3G 1A4, Canada
[3] McGill Univ, Montreal, PQ, Canada
[4] Continuum Heart Inst, Ctr Innovat Cardiovasc Therapy, New York, NY USA
基金
英国医学研究理事会;
关键词
cyclooxygenase-2; myocardial infarction; selective COX-2 inhibitor; rat;
D O I
10.1006/bbrc.2000.3010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Induction of cyclooxygenase-a (COX-2) in ischemic myocardium is thought to increase the production of proinflammatory prostanoids and contribute significantly to the ischemic inflammation. Left ventricular myocardial infarction (MI) was created by ligating the left coronary artery in Lewis rats. Hemodynamic measurements at 4 weeks showed better cardiac function in the group treated with a selective COX-2 inhibitor (DFU; 5 mg/kg/day) for 2 weeks after induction of MI compared to the vehicle treated group. These results suggest that induction of COX-2 contributes to myocardial dysfunction, and that selective inhibition of COX-2 could constitute an important therapeutic target for the treatment of MI. (C) 2000 Academic Press.
引用
收藏
页码:772 / 775
页数:4
相关论文
共 50 条
  • [1] Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse
    LaPointe, MC
    Mendez, M
    Leung, A
    Tao, ZY
    Yang, XP
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (04): : H1416 - H1424
  • [2] New aspects of cyclooxygenase-2 inhibition in myocardial infarction and ischaemia
    Saeed, S. A.
    Ahmed, S.
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 2005, 117 : 167 - 178
  • [3] Inhibition of cyclooxygenase-2 improves cardiac function following long-term preservation
    Oshima, Kiyohiro
    Takeyoshi, Izumi
    Tsutsumi, Hirofumi
    Mohara, Jun
    Ohki, Shigeru
    Koike, Norimasa
    Nameki, Taro
    Matsumoto, Koshi
    Morishita, Yasuo
    JOURNAL OF SURGICAL RESEARCH, 2006, 135 (02) : 380 - 384
  • [4] Effects of Selective Cyclooxygenase-2 and Nonselective Cyclooxygenase Inhibition on Myocardial Function and Perfusion
    Robich, Michael P.
    Chu, Louis M.
    Burgess, Thomas A.
    Feng, Jun
    Bianchi, Cesario
    Sellke, Frank W.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2011, 57 (01) : 122 - 130
  • [5] The risk for myocardial infarction with cyclooxygenase-2 inhibitors
    Kim, JA
    Choi, YS
    Yoon, DY
    Cho, KH
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (08) : 615 - 616
  • [6] Inhibition of cyclooxygenase-2 reduces infarct size following myocardial infarction in the rat
    He, Q
    Yang, XP
    LaPointe, MC
    HYPERTENSION, 2001, 38 (03) : 511 - 511
  • [7] Cyclooxygenase-2 inhibition and renal function
    Pfister, AK
    Crisalli, RJ
    Carter, WH
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (11) : 1077 - 1077
  • [8] Calmodulin kinase inhibition improves cardiac function after myocardial infarction
    Khoo, MS
    Zhang, R
    Grueter, CE
    Ni, GM
    Painter, C
    Eren, M
    Gleaves, L
    Price, E
    Yang, JY
    Madu, EC
    Vaughan, DE
    Anderson, ME
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 255A - 255A
  • [9] Risk of myocardial infarction by type of cyclooxygenase-2 inhibitor
    Kimmel, SE
    Berlin, JA
    Reilly, M
    Jaskowiak, J
    Kishel, L
    Strom, BL
    CIRCULATION, 2003, 108 (17) : 752 - 752
  • [10] Cyclooxygenase-2 inhibition and renal function - Response
    Swan, SK
    Brater, DC
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (11) : 1078 - 1078